VYOME HOLDINGS, INC.

HIND ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014
Revenue $9.9M $3.4M $4.0M $3.5M
Cost of Revenue $4.8M $2.8M $2.5M $2.9M
Gross Profit $5.1M $584.0K $1.5M $627.0K
Gross Margin 51.3% 17.2% 38.0% 17.7%
Operating Expenses
Research & Development $10.6M $9.9M $13.0M $5.8M
SG&A Expense $28.8M $10.2M $3.5M $4.7M
Operating Income $-34.4M $-19.5M $-14.9M $-9.8M
Operating Margin -346.9% -574.9% -369.7% -278.0%
Interest Expense
Pretax Income
Income Tax Expense $10.0K $2.0K $-13.0K $16.0K
Net Income $-34.8M $-20.5M $-15.6M $-9.9M
Net Margin -350.7% -603.2% -385.2% -279.5%
EPS (Basic) $-0.10 $-0.24 $-1.36 $-0.93
EPS (Diluted) $-0.10 $-0.24 $-1.36 $-0.93
Shares Outstanding (Basic) 350.0M 335.5M 11.5M
Shares Outstanding (Diluted) 350.0M 335.5M 11.5M
Dividends Per Share
← Newer Page 2 of 2 Older →